Neuroblastoma: estrategias mecanoterapéuticas basadas en modelos 3D y tumores derivados de pacientes con microambiente rico en vitronectina

Datos básicos

Protocolo:
PI20/01107
EUDRACT:
NCT:
Centro:
UNIVERSIDAD DE VALENCIA
Año de incio:
2021
Año de finalización:
2024
PROYECTO DE INVESTIGACIÓN NACIONAL F.COMPETITIVA FIN. PUBLICA 232.320,00 €

Documentos

  • No hay documentos

Participantes

Grupos y Plataformas de I+D+i

Financiadores - Promotores

INSTITUTO SALUD CARLOS III

Resultados del Ensayo Clínico


Characterization of Vitronectin Effect in 3D Ewing Sarcoma Models: A Digital Microscopic Analysis of Two Cell Lines.

López-Carrasco, A; (...); Noguera, R

Article. 10.3390/cancers16193347. 2024

  • Open Access.

Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma.

Sanegre, S; (...); Noguera, R

Article. 10.3389/fcell.2021.670185. 2021


Digital image analysis workflows for evaluation of cell behavior and tumor microenvironment to aid therapeutic assessment in high-risk neuroblastoma

Stoks, M; (...); Noguera, R

Article. 10.1016/j.compbiomed.2023.107364. 2023


Immunometabolism Modulation in Therapy.

Monferrer, E; (...); Naranjo, TA

Article. 10.3390/biomedicines9070798. 2021


Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study.

Corallo, Diana; (...); Aveic, Sanja

Article. 10.3390/cells10102695. 2021


Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma.

Lopez-Carrasco, Amparo; (...); Noguera, Rosa

Article. 10.3390/cancers13205173. 2021


Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction.

Monferrer, Ezequiel; (...); Alvaro Naranjo, Tomas

Article. 10.3390/metabo11050264. 2021


Real-time morphometric analysis of targeted therapy for neuroblastoma cells in monolayer and 3D hydrogels using digital holographic microscopy.

Granados-Aparici, S; (...); Noguera, R

Article. 10.1016/j.isci.2024.111231. 2024

  • Open Access.

Risk of developing neuroblastoma influenced by maternal stressful life events during pregnancy and congenital pathologies

Benavent N; (...); Tadeo I

Article. 10.1002/pbc.31402. 2025

  • Open Access.

The complexity of cancer immunotherapy illustrated through skin tumors.

Vieco-Marti, I; (...); Alvaro Naranjo, T

Article. 10.1177/03936155221088884. 2022


The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models.

Masanas, Marc; (...); Segura, Miguel F

Letter. 10.1002/ctm2.533. 2021


Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma.

Burgos-Panadero, Rebeca; (...); Noguera, Rosa

Article. 10.1016/j.ijpharm.2021.121058. 2021

  • Open Access.

Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?

López-Carrasco A; (...); Noguera R

Article. 10.3390/ijms25168733. 2024

  • Open Access.

Compartir